Back To Search Results

Dr Sumit Kumar Sonu

MBBS(India), MRCP(UK), MRCPE(Edin.) PGDip(Diabetes)USW,FAMS (Neurology), FRCP Edin.

Consultant

Specialty: Neurology

Sub-specialties: General Neurology, Stroke, Interventional Neurology

Conditions Treated by this Doctor:
General Neurology.

Clinical Appointments

Consultant, Department of Neurology, National Neuroscience Institute (NNI@SGH) Neurology Singapore General Hospital
Fellow of Academy of Medicine Singapore, Chapter of Neurology
Fellow, Royal College of Physicians of Edinburgh

Academic Appointments

Core Faculty SingHealth Neurology Senior Residency
COMBINE (Collaboration for Mmed-FM programme B In Neurology Education) Programme Course director
Clinical Teacher, Lee Kong Chian School of Medicine
Clinical Instructor, Duke-NUS
PGY1 Faculty, Singapore General Hospital
Singapore General Hospital (Cadence PACES tutor)

Profile

Dr Sumit Kumar Sonu is a Consultant, Department of Neurology at the National Neuroscience Institute (NNI@SGH). He joined the SingHealth Internal Medicine Residency and subsequently completed his Senior Residency in Neurology in 2021.

Education

FRCP Edin. 2023
FAMS (Neurology)2021
SingHealth Neurology Senior Residency 2021
SingHealth Internal medicine Residency 2018
MRCP (UK), Neurology, 2020
Postgraduate Diploma in Diabetes, University of South Wales, UK, 2017
MRCP (UK), 2014
MBBS (Madras Medical College /Dr MGR Tamilnadu Medical University), 2008

Professional Appointments and Committee Memberships

Member, Word Stroke Organisation
Member, European Stroke Organisation
Member, American Academy of Neurology
Corresponding Member, European Academy of Neurology
Collegiate Member, Royal College of Physicians and Surgeons of Glasgow
Member of Society of Neurovascular Intervention and Surgery (Singapore )
Committee member of chapter of neurology, Fellow of Academy of Medicine Singapore

Awards

The COVID-19 RESILIENCE Medal 2023
SingHealth 10 years Long Service Award 2022
NNI 10 years Long Service Award 2022
Service with a Heart Award – SingHealth Service Quality Day 2021
IPSQ Poster Excellence Award – SingHealth Duke-NUS Quality & Innovation Day 2021
Certificate of Appreciation for Contribution in Fight Against COVID-19 – SingHealth Residency
Outstanding Resident Award – SingHealth RiSE Award 2020
Bronze Award – NNI Quality Improvement Project Award 2019
Best Quality Improvement Project Award – SingHealth Division of Medicine, Singapore General Hospital, 2018

Research Interests

Publications

Shawn Zhi Zheng Lin; Marco Lizwan; Mark Bangwei Tan; Sumit Kumar Sonu. Case of infiltrative optic neuropathy with hypertrophic pachymeningitis as a manifestation of en plaque meningioma. BMJ Case Reports 2023-12 | Journal article DOI: 10.1136/bcr-2023-257046 (Case report; Published in Print)
Sarah Hasnor Abu Hassan; Sumit Kumar Sonu. Paraneoplastic seropositive AQP4-IgG neuromyelitis optica spectrum disorder associated with sigmoid adenocarcinoma. Neurology Asia 2023; 28(3) : 769 – 774| Journal article. DOI: 10.54029/2023kvu Case report; Published in Print)
Marco Lizwan, Sumit Kumar Sonu. Bilateral Thalamic Infarction Caused by Artery of Percheron Obstruction. BMJ Case Rep. 2023 Jan 13;16(1):e253949. DOI: 10.1136/bcr-2022-253949. PMID: 36639198 (Case report; Published in Print)
Marco Lizwan; Shawn Zhi Zheng Lin; Sumit Kumar Sonu. Rare case of anti-CV2 paraneoplastic polyneuropathy associated with lung adenocarcinoma. BMJ Case Rep. 2023 Feb 3;16(2):e253686. DOI: 10.1136/bcr-2022-253686 PMID: 36737068 (Case report; Published in Print)
Sonu SK, Yong MH, Koh YH. Small fiber neuropathy in a patient with coronavirus disease 2019 (COVID-19). Neurol Asia. 2022 Mar; 27(1):195-197. doi: 10.54029/2022wzy. (Case report; Published in Print)
Sonu SK, Ng JCH, Chua SM, Kumar MP, De Silva D. Chorea precipitated by phototherapy as initial presentation of systemic lupus erythematosus. Ann Acad Med Singap. 2021 Oct;50(10):788-790. doi: 10.47102/annals-acadmedsg.2021137. PMID: 34755174. (Case report; Published in Print)
Tan JY, Sonu SK, Jion YBI, Umapathi T. Acute dysphagia. Pract Neurol. 2021 Jun;21(3):255-256. doi: 10.1136/practneurol-2020-002728. Epub 2021 Mar 1. PMID: 33649168. (Case report; Published in Print)
Sonu SK, Lalmalani Y, Kumar S, Verma, K. Acute acro-paraesthesia and bilateral clumsy hand syndrome rare presenting manifestation of vitamin B 12 deficiency: a case report highlighting clinico-radiological findings at diagnosis and follow-up. Neurol Asia. 2020 Dec; 25(4):627-630. Available from: https://imsva91-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fwww.neurology%2dasia.org%2farticles%2fneuroasia%2d2020%2d25%284%29%2d627.pdf&umid=786A1719-0CF2-7506-BDBA-E033BFDFC045&auth=6e3fe59570831a389716849e93b5d483c90c3fe4-58819f2d4fc8f61a9967c6748888b56daf772106. (Case report; Published in Print)
Sonu SK, Lai YW, Verma K, Sitoh YY, Purohit B. Enterovirus-related rhombencephalitis and myelitis in the third trimester of pregnancy: A case report highlighting clinico-radiological findings at diagnosis and follow-up, Radiol Case Rep. 2020 Aug;15(8):1323-1330. doi: 10.1016/j.radcr.2020.05.062. Epub 2020 Jun 23. PMID: 32612733; PMCID: PMC7322137. (Case report; Published in Print)
Shekhawat RS, Lim WEH, Yong KP, De Silva DA, Sonu KS. “Heartbeat in the head”–An atypical presentation of dural arteriovenous malformation. Case Rep Intern Med. 2018 Oct; 5(4):19-22. doi: 10.5430/crim.v5n4p19. (Case report; Published in Print)

Research Trials

STROKE:

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT)
TEMPO-2 acute stroke clinical trial
DIRECT-SAFE Clinical Trial
Brushing Up on Oral Hygiene - Perceptions and Practices of Stroke Survivors/ Caregivers on Oral Care in Stroke Patients
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients with Stroke
Genetic Screening study of Young Ischemic Stroke patients (GeneSYIS)
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack (LIBREXIA-STROKE)
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke

HEADACHE:

A Real-life study of Eptinezumab (Vyepti) in Asian Patients with migraine (REAP STUDY)

PARKINSON’S:

A Phase IIb, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Titrations Study to Evaluate the Efficacy and Safety of AM006 in Patients with Early Parkinson 's Disease without Levodopa

Tags: Neurology, General Neurology, Stroke, Interventional Neurology, General Neurology